DK0655065T3 - - Google Patents

Info

Publication number
DK0655065T3
DK0655065T3 DK93919994.9T DK93919994T DK0655065T3 DK 0655065 T3 DK0655065 T3 DK 0655065T3 DK 93919994 T DK93919994 T DK 93919994T DK 0655065 T3 DK0655065 T3 DK 0655065T3
Authority
DK
Denmark
Prior art keywords
hydroxyrapamycin
formula
compound
deoxo
immunosuppressive
Prior art date
Application number
DK93919994.9T
Other languages
Danish (da)
English (en)
Inventor
Frances Christy Nelson
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/009,605 external-priority patent/US5256790A/en
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of DK0655065T3 publication Critical patent/DK0655065T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK93919994.9T 1992-08-13 1993-08-12 DK0655065T3 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93012492A 1992-08-13 1992-08-13
US08/009,605 US5256790A (en) 1992-08-13 1993-01-27 27-hydroxyrapamycin and derivatives thereof

Publications (1)

Publication Number Publication Date
DK0655065T3 true DK0655065T3 (ru) 1997-02-24

Family

ID=26679675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93919994.9T DK0655065T3 (ru) 1992-08-13 1993-08-12

Country Status (12)

Country Link
EP (1) EP0655065B1 (ru)
JP (1) JPH08501084A (ru)
AT (1) ATE146179T1 (ru)
AU (1) AU5007193A (ru)
CA (1) CA2142288A1 (ru)
DE (1) DE69306585T2 (ru)
DK (1) DK0655065T3 (ru)
ES (1) ES2096941T3 (ru)
GR (1) GR3022730T3 (ru)
HU (1) HU221499B (ru)
MX (1) MX9304868A (ru)
WO (1) WO1994004540A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014023A1 (en) * 1993-11-19 1995-05-26 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
CZ292233B6 (cs) * 1995-06-09 2003-08-13 Novartis Ag Deriváty rapamycinu a jejich použití jako léčiv
AU783158B2 (en) 1999-08-24 2005-09-29 Ariad Pharmaceuticals, Inc. 28-epirapalogs
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
US20030220297A1 (en) 2002-02-01 2003-11-27 Berstein David L. Phosphorus-containing compounds and uses thereof
CA2511521C (en) 2002-12-30 2012-02-07 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
CA2669415A1 (en) 2006-11-14 2008-05-22 Ariad Pharmaceuticals, Inc. Solid dosage form comprising ap23573
WO2009089549A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
EP3008192B1 (en) 2013-06-11 2019-07-17 Takara Bio USA, Inc. Protein enriched microvesicles and methods of making and using the same
JP7381492B2 (ja) 2018-05-01 2023-11-15 レヴォリューション・メディスンズ，インコーポレイテッド Ｍｔｏｒ阻害剤としてのｃ２６－連結ラパマイシン類似体
CA3214664A1 (en) * 2021-04-09 2022-10-13 Steven G. Ballmer Synthesis of rapamycin analog compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04230389A (ja) * 1990-07-16 1992-08-19 American Home Prod Corp ラパマイシン誘導体
US5102876A (en) * 1991-05-07 1992-04-07 American Home Products Corporation Reduction products of rapamycin

Also Published As

Publication number Publication date
HU9500432D0 (en) 1995-04-28
DE69306585D1 (de) 1997-01-23
ES2096941T3 (es) 1997-03-16
EP0655065B1 (en) 1996-12-11
JPH08501084A (ja) 1996-02-06
EP0655065A1 (en) 1995-05-31
HUT71614A (en) 1996-01-29
AU5007193A (en) 1994-03-15
DE69306585T2 (de) 1997-04-17
ATE146179T1 (de) 1996-12-15
CA2142288A1 (en) 1994-03-03
HU221499B (en) 2002-10-28
WO1994004540A1 (en) 1994-03-03
GR3022730T3 (en) 1997-06-30
MX9304868A (es) 1994-05-31

Similar Documents

Publication Publication Date Title
ES2085726T3 (es) Derivado prolinico de rapamicina, su produccion y aplicacion.
HK1011354A1 (en) Heterocyclic esters of rapamycin and pharmaceutical compositions containing them
DK0655065T3 (ru)
NZ297661A (en) Hindered N-oxide esters of rapamycin and pharmaceutical compositions
ES2069137T3 (es) Derivados de imidazopiridina y su uso.
TW360678B (en) Synergistic stabilizer mixture for polyolefins
EP0630898A4 (en) MEDICINE FOR THROMBOZYTOPENIA.
CA2074533A1 (en) 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient
NO974890D0 (no) Radicicolderivater
MY107303A (en) N-phenylpyrazole derivatives as insecticides.
JO1704B1 (en) New potent compounds
AU2623192A (en) Antifungal agent
GB9325618D0 (en) New herbicides
CA2111955A1 (en) Novel tetracyclic compound
AU621996B2 (en) 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi2 derivatives
UY24327A1 (es) Derivados de cefalosporina
MY115430A (en) Glutaramide derivatives.
AU1446892A (en) Novel oxa- or azasteroid derivative
AU7020996A (en) UCK14 compounds
AP9400608A0 (en) "New nicotinic acid derivative".
CA2032311A1 (en) 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors